Company-level financial information

IRADIMED CORP

Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.

Annual net income

202020212022202320242025

Reported annual periods; USD. Negative values extend below the baseline.

Selected annual US-GAAP cash-flow and earnings facts · USD
Reporting periodMeasureUSD millionsFiling
Dec 31, 2025From Jan 1, 2025Operating cash flow24.9SEC filingMar 6, 2026
Dec 31, 2025From Jan 1, 2025Net income22.5SEC filingMar 6, 2026
Dec 31, 2025From Jan 1, 2025Total cash dividends15.0SEC filingMar 6, 2026
Dec 31, 2025From Jan 1, 2025Capital expenditures (PP&E)7.8SEC filingMar 6, 2026
Dec 31, 2024From Jan 1, 2024Operating cash flow25.6SEC filingMar 6, 2026
Dec 31, 2024From Jan 1, 2024Net income19.2SEC filingMar 6, 2026
Dec 31, 2024From Jan 1, 2024Total cash dividends13.7SEC filingMar 6, 2026
Dec 31, 2024From Jan 1, 2024Capital expenditures (PP&E)8.0SEC filingMar 6, 2026
Dec 31, 2023From Jan 1, 2023Operating cash flow13.5SEC filingSep 3, 2025
Dec 31, 2023From Jan 1, 2023Net income17.2SEC filingSep 3, 2025
Dec 31, 2023From Jan 1, 2023Total cash dividends13.2SEC filingSep 3, 2025
Dec 31, 2023From Jan 1, 2023Capital expenditures (PP&E)7.4SEC filingSep 3, 2025
Dec 31, 2022From Jan 1, 2022Operating cash flow10.0SEC filingMar 1, 2024
Dec 31, 2022From Jan 1, 2022Net income12.8SEC filingMar 1, 2024
Dec 31, 2022From Jan 1, 2022Total cash dividends12.6SEC filingMar 1, 2024
Dec 31, 2022From Jan 1, 2022Capital expenditures (PP&E)0.8SEC filingMar 1, 2024
Dec 31, 2021From Jan 1, 2021Operating cash flow11.3SEC filingMar 2, 2023
Dec 31, 2021From Jan 1, 2021Net income9.3SEC filingMar 2, 2023
Dec 31, 2021From Jan 1, 2021Capital expenditures (PP&E)0.5SEC filingMar 2, 2023
Dec 31, 2020From Jan 1, 2020Operating cash flow5.8SEC filingMar 4, 2022
Dec 31, 2020From Jan 1, 2020Net income1.4SEC filingMar 4, 2022
Dec 31, 2020From Jan 1, 2020Capital expenditures (PP&E)0.4SEC filingMar 4, 2022
Dec 31, 2019From Jan 1, 2019Operating cash flow10.2SEC filingMar 4, 2022
Dec 31, 2019From Jan 1, 2019Net income9.6SEC filingMar 4, 2022
Dec 31, 2019From Jan 1, 2019Capital expenditures (PP&E)0.4SEC filingMar 4, 2022

Latest filed value per tag and exact annual period, within the last seven years. Common-stock and total cash dividends are separate measures; do not add them together. These selected facts are not a complete financial statement.